Chlorine in PDB 4lxd: BCL_2-Navitoclax Analog (Without Thiophenyl) Complex

The structure of BCL_2-Navitoclax Analog (Without Thiophenyl) Complex, PDB code: 4lxd was solved by C.H.Park, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	37.46 / 1.90
Space group	P 61
Cell size a, b, c (Å), α, β, γ (°)	86.515, 86.515, 62.425, 90.00, 90.00, 120.00
R / Rfree (%)	18 / 21.2

The binding sites of Chlorine atom in the BCL_2-Navitoclax Analog (Without Thiophenyl) Complex (pdb code 4lxd). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the BCL_2-Navitoclax Analog (Without Thiophenyl) Complex, PDB code: 4lxd:

Chlorine binding site 1 out of 1 in the BCL_2-Navitoclax Analog (Without Thiophenyl) Complex


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of BCL_2-Navitoclax Analog (Without Thiophenyl) Complex within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl301 b:28.1 occ:1.00 CL4 A:1XV301 0.0 28.1 1.0 C18 A:1XV301 1.7 23.6 1.0 C9 A:1XV301 2.7 22.0 1.0 C10 A:1XV301 2.7 20.8 1.0 CD2 A:PHE109 3.7 26.4 1.0 CG2 A:VAL153 3.9 20.0 1.0 C1 A:1XV301 4.0 21.1 1.0 C2 A:1XV301 4.0 20.7 1.0 C A:GLU149 4.1 14.4 1.0 CB A:GLU149 4.1 12.5 1.0 O A:GLU149 4.1 13.8 1.0 N A:PHE150 4.1 11.5 1.0 CE2 A:PHE101 4.3 20.8 1.0 CA A:PHE109 4.3 19.4 1.0 CA A:PHE150 4.3 12.1 1.0 CE2 A:PHE109 4.4 29.5 1.0 C12 A:1XV301 4.5 22.1 1.0 CG A:PHE109 4.5 24.1 1.0 CB A:PHE109 4.5 21.5 1.0 OG A:SER102 4.6 21.3 0.5 CA A:GLU149 4.7 11.6 1.0 CG A:MET112 4.7 28.0 1.0 CB A:MET112 4.7 24.8 1.0 O A:ALA146 4.9 14.9 1.0 CB A:PHE150 4.9 13.1 1.0 CB A:VAL153 4.9 20.3 1.0 N A:PHE109 4.9 18.9 1.0 CD2 A:PHE101 5.0 18.3 1.0

A.J.Souers, J.D.Leverson, E.R.Boghaert, S.L.Ackler, N.D.Catron, J.Chen, B.D.Dayton, H.Ding, S.H.Enschede, W.J.Fairbrother, D.C.Huang, S.G.Hymowitz, S.Jin, S.L.Khaw, P.J.Kovar, L.T.Lam, J.Lee, H.L.Maecker, K.C.Marsh, K.D.Mason, M.J.Mitten, P.M.Nimmer, A.Oleksijew, C.H.Park, C.M.Park, D.C.Phillips, A.W.Roberts, D.Sampath, J.F.Seymour, M.L.Smith, G.M.Sullivan, S.K.Tahir, C.Tse, M.D.Wendt, Y.Xiao, J.C.Xue, H.Zhang, R.A.Humerickhouse, S.H.Rosenberg, S.W.Elmore. Abt-199, A Potent and Selective Bcl-2 Inhibitor, Achieves Antitumor Activity While Sparing Platelets. Nat.Med. (N.Y.) V. 19 202 2013.
ISSN: ISSN 1078-8956
PubMed: 23291630
DOI: 10.1038/NM.3048